Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

Introduction and Aims: HCV eradication by direct-acting antivirals (DAAs) improves liver outcomes and reduces overall liver mortality. However, patients with advanced chronic liver disease (ACLD) may experience a progression of liver disease despite viral clearance. Silybin has shown hepatoprotectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cossiga, Valentina, Sanduzzi-Zamparelli, Marco, Sapena, Victor, Guarino, Maria, Dallio, Marcello, Torrisi, Emanuele, Pignata, Luca, Federico, Alessandro, Salomone, Federico, Morisco, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847679/
https://www.ncbi.nlm.nih.gov/pubmed/35185575
http://dx.doi.org/10.3389/fphar.2022.824879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847679/
https://www.ncbi.nlm.nih.gov/pubmed/35185575
http://dx.doi.org/10.3389/fphar.2022.824879

Ejemplares similares